Because of a growing menu of effective treatments, people with multiple myeloma (MM) can now have longer disease-free periods. In many cases, though, the cancer returns (relapses) or begins to grow ...

The U.S. Food and Drug Administration (FDA) has accepted a new drug application for iberdomide combined with Darzalex ...

Study expected to enroll 24 patients with the option to enroll an additional 45 patients at the recommended Phase 2 doseProtocol calls for three doses of STAR-LLD administered by continuous ...

A myeloma survivor in long remission shares how research, expert care and advocacy turned fear into hope as more patients ...

If you have multiple myeloma, your chances of surviving it are better than ever. But people of different races, genders, socioeconomic levels, and ages often don’t get equal care. They also don't have ...

Bristol Myers Squibb said the U.S. Food and Drug Administration has granted priority review to its application seeking approval of its iberdomide drug candidate in certain patients with the blood ...

The FDA has accepted Bristol Myers Squibb (BMS)’s New Drug Application (NDA) for iberdomide for relapsed or refractory ...

Renowned Hindi and Marathi actress Pravina Deshpande passed away at 60 after battling multiple myeloma since 2019. Known for Ghar Ek Mandir, Kumkum, and films like Ready, she faced skin eruptions, ...

Radiation therapy is a treatment that uses high doses of radiation to damage cancer cells, either killing them or slowing their growth. Unlike the low-dose radiation used in X-rays to see inside the ...

Don’t let medication side effects or other issues throw you off course. There are plenty of strategies for overcoming the challenges of cancer therapy. Going through treatment for multiple myeloma is ...

Experts explore the evolving goals in treating newly diagnosed patients with multiple myeloma, including balancing effective therapies, achieving MRD-negative remission, and managing toxicities. This ...

The future of CAR T therapy may be entwined with another modern innovation: mRNA technology. This duo may solve long-standing problems with standard CAR T therapy for cancers such as multiple myeloma.